2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
2024
Jun 26, 2024, 11:01 |
Blog
Cancer Research Institute's virtual Patient Immunotherapy Summit
Cancer Research Institute (CRI) shared on LinkedIn: ""I was one of the first lung cancer…
Jun 26, 2024, 10:24 |
Blog
Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?
Chandler Park shared on X: . "Which patients would…
Jun 26, 2024, 09:54 |
Insight
Miguel Bronchud: How often is post-recurrence treatment reported in adjuvant and neoadjuvant oncology randomized clinical trials?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Clinical trials- not “real life”? They…
Jun 26, 2024, 09:38 |
Blog
Katia Roque: Two poster presentations about cervical cancer and GTN at ESMOgynae2024
Katia Roque, Clinical Oncologist at INEN, shared on X: "A great ESMOgynae2024! Two poster presentations…
Jun 26, 2024, 08:52 |
Blog
Richard Scolyer: Amazing advances in medicine over the past half century
Richard Scolyer shared on X: "Medicine has made many amazing advances over the past half…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 26, 2024, 08:29 |
Blog
Deniz Can Guven: Excited to see younger brother grow with the mentorship of Yuksel Urun
Deniz Can Guven, Editorial Board Member of BMC Cancer, shared a post by Enes Erul,…
Jun 26, 2024, 08:17 |
Insight
Comprehensive review of colorectal cancer by Cathy Eng et al.
Arndt Vogel shared on X: "Colorectal cancer in The Lancet: comprehensive review locoregional options: SBRT…
Jun 26, 2024, 08:00 |
Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 26, 2024, 07:54 |
Insight
Importance of ctDNA turn around
Aparna Parikh shared on X: "More on adjuvant timing. Will be interesting to see surveillance ctDNA…
643
644
645
646
647
All:
15461
Posts:
6441 - 6450
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube